Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China

2 weeks ago

MONTREAL and CHARLOTTE, N.C., Sept. 06, 2024 ( GLOBE NEWSWIRE ) -- Milestone® Pharmaceuticals Inc. ( Nasdaq: MIST ) , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced its licensing partner, Ji Xing ...

Ticker	Sentiment	Impact
MIST	Somewhat Bullish	11 %